Cell Therapeutics (CTIC) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Cell Therapeutics (CTIC)

CTIC 9.090

0.0%

Jun 26 5:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: tuck who wrote (694)	6/15/2005 2:41:56 PM
From: Ian@SI	Read Replies (3) of 946

Tuck, MF seems a little harsh, but an accurate reflection of the market's reaction. CTIC has a market cap of $168M. (65M shares outstanding). Trisenox deal of $70M now with up to $100M possible seems awfully close to what the market thinks the whole company is worth. If I understood the PR, the Trisenox deal also included the staff associated with it - and that should get rid of a lot of overhead cutting the burn rate nicely. I don't believe that Xyotax is worthless, far from it. You also believe that Pix has some value. Total current assets 3/31 were $87M. With $40M from the sale, an 8M/mo burn rate yields about 16 Months. Hopefully that will be enough time to move the ball forward and attract a partner with deep pockets. Ian

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next